Peripheral Arterial Disease Trial, Recruiting NCT07283289 Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07283289
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with peripheral artery disease (a condition affecting blood flow in the limbs) and are being seen either in hospital or at an outpatient vascular clinic, at any stage of the condition and regardless of whether you have had surgery before
  • You are willing to allow your anonymised medical information to be used for this study
  • You already have a sleep monitoring test (called a polygraphy) planned as part of your normal care within the next month

Who may not be able to join:

  • You are unable to complete a blood pressure comparison test between your ankle and arm (called an Ankle-Brachial Index) or a sleep monitoring test, due to physical or cognitive difficulties such as severe memory problems or limb differences (confirm with trial site)
  • You have already been diagnosed with obstructive sleep apnoea (a condition where breathing repeatedly stops during sleep) confirmed by a previous sleep test, and you are currently using a nighttime breathing machine (such as a CPAP device) to treat it

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Léonie GEY, M.D., Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

Phone: 04 94 14 50 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Registry
ClinicalTrials.gov
Start date
5 November 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion of patients diagnosed with OSAS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov